Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Tranexamic Acid vs Adrenaline for Controlling Iatrogenic Bleeding During Flexible Bronchoscopy (CROSBI ID 317133)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Badovinac, Sonja ; Glodić, Goran ; Sabol, Ivan ; Džubur, Feđa ; Jankovic Makek, Mateja ; Baričević, Denis ; Koršić, Marta ; Popović, Filip ; Srdić, Dražena ; Samaržija, Miroslav Tranexamic Acid vs Adrenaline for Controlling Iatrogenic Bleeding During Flexible Bronchoscopy // Chest, 163 (2022), 4; 985-993. doi: 10.1016/j.chest.2022.10.013

Podaci o odgovornosti

Badovinac, Sonja ; Glodić, Goran ; Sabol, Ivan ; Džubur, Feđa ; Jankovic Makek, Mateja ; Baričević, Denis ; Koršić, Marta ; Popović, Filip ; Srdić, Dražena ; Samaržija, Miroslav

engleski

Tranexamic Acid vs Adrenaline for Controlling Iatrogenic Bleeding During Flexible Bronchoscopy

Background The most commonly used topical hemostatic agents during flexible bronchoscopy (FB) are cold saline and adrenaline. Data on use of other agents such as tranexamic acid (TXA) for this purpose are limited. Research Question Is TXA effective and safe in controlling iatrogenic bleeding during FB compared with adrenaline? Study Design and Methods We conducted a cluster- randomized, double-masked, single-center trial in a tertiary teaching hospital. Patients were randomized in weekly clusters to receive up to three applications of TXA (100 mg, 2 mL) or adrenaline (0.2 mg, 2 mL, 1:10000) after hemostasis failure after three applications of cold saline (4°C, 5 mL). Crossover was allowed (for up to three further applications) before proceeding with other interventions. Bleeding severity was graded by the bronchoscopist using a visual analog scale (VAS ; 1 = very mild, 10 = severe). Results A total of 2, 033 FBs were performed and 130 patients were randomized successfully to adrenaline (n = 65) or TXA (n = 65), whereas 12 patients had to be excluded for protocol violations (two patients from the adrenaline arm and 10 patients from TXA arm). Bleeding was stopped in 83.1% of patients (54/65) in both groups (P = 1). The severity of bleeding and number of applications needed for bleeding control were similar in both groups (adrenaline: mean VAS score, 4.9 ± 1.3 [n = 1.8 ± 0.8] ; TXA: mean VAS score, 5.3 ± 1.4 [n = 1.8 ± 0.8]). Both adrenaline and TXA were more successful in controlling moderate bleeding (86.7% and 88.7%, respectively) than severe bleeding (40% and 58.3%, respectively ; P = .008 and P = .012, respectively) and required more applications for severe bleeding (3.0 ± 0 and 2.4 ± 0.5, respectively) than moderate bleeding (1.7 ± 0.8 and 1.7 ± 0.8, respectively) control (P = .006 and P = .002, respectively). We observed no drug- related adverse events in either group. Interpretation We found no significant difference between adrenaline and TXA for controlling noncatastrophic iatrogenic endobronchial bleeding after cold saline failure, adding to the body of evidence that TXA can be used safely and effectively during FB.

adrenaline ; bronchoscopy ; endobronchial bleeding ; tranexamic acid

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

163 (4)

2022.

985-993

objavljeno

0012-3692

1931-3543

10.1016/j.chest.2022.10.013

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost